Related Experiment Videos
Prostaglandins and rat glomerular mesangial cell proliferation
1Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Kidney International
|May 1, 1990
Summary
Prostaglandin F2 alpha (PGF2 alpha) promotes rat mesangial cell growth, while Iloprost inhibits it. These findings suggest prostaglandins regulate mesangial cell proliferation in the kidney.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- Arachidonate metabolites influence glomerular mesangial cell contractility via phospholipase C or adenylate cyclase signaling.
- Intracellular signals like calcium, pH, and cyclic adenosine 3'5'-monophosphate (cAMP) affect cell growth.
- Eicosanoids are known to impact cell proliferation.
Purpose of the Study:
- To investigate the effects of prostaglandin F2 alpha (PGF2 alpha) and Iloprost on rat mesangial cell DNA synthesis and proliferation.
- To determine the role of specific signaling pathways (phospholipase C and adenylate cyclase) in mesangial cell growth regulation by eicosanoids.
Main Methods:
- Rat mesangial cell cultures were exposed to prostaglandin F2 alpha (PGF2 alpha) or Iloprost.
- DNA synthesis and cell number were measured to assess proliferation.
- The effects of these compounds were evaluated with and without insulin, platelet-derived growth factor (PDGF), or fetal serum.
Main Results:
- PGF2 alpha dose-dependently enhanced DNA synthesis and proliferation in the presence of insulin (EC50 = 0.1 microM), potentiating PDGF and serum effects.
- Short-term PGF2 alpha exposure (30 min) had a lasting mitogenic effect.
- Iloprost inhibited growth stimulated by fetal serum but had no effect on quiescent cells.
Conclusions:
- Prostaglandin F2 alpha acts as a mitogen for rat mesangial cells, particularly in conjunction with insulin or growth factors.
- Iloprost exhibits inhibitory effects on mesangial cell proliferation.
- Glomerular prostaglandins may play a crucial role in regulating mesangial cell growth under physiological and pathological conditions.